PPD Awarded U.S. Army Contract

PPD, Inc. has been awarded the U.S. Army Medical Research Acquisition Activity: Regulatory Affairs & Compliance Support contract to provide global regulatory and biostatistic services for a range of U.S. Army funded clinical development programs. The multi-year, indefinite delivery, indefinite quantity (IDIQ) contract has maximum value of $45.5 million for a five-year period.

PPD will provide regulatory and consulting services to aid the U.S. Army in preparing and filing clinical trial submissions to the FDA and other regulatory authorities worldwide. PPD will support the Army’s biodefense, biopreparedness and vaccine development initiatives aimed at protecting military personnel. PPD will also provide statistical consulting, study design and statistical analysis support.

“This contract enables us to deliver on our breadth of global regulatory and biostatistics services and assist the U.S. Army in advancing clinical programs that improve the health of men and women serving in our armed forces,” said Henrietta Ukwu, M.D., senior vice president of global regulatory affairs for PPD. “We are pleased to partner with the U.S. Army in this effort and to continue to extend our long history of partnering with the U.S. Government on clinical research and development.”